Alinity 08P4930Recalls & reported problems
Abbott GmbH · Alinity i CA 125 II Reagent Kit 1000 Tests · Class 2
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380740131050), received between Apr 24, 2024 and Mar 20, 2026 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “High Test Results” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- High Test Results1
- Low Test Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 20, 2026Low Test Results
THE CUSTOMER OBSERVED A FALSE DEPRESSED ALINITY I CA 125 II RESULT FOR A 70-YEAR-OLD FEMALE PATIENT THAT HAS BEEN DIAGNOSED WITH OVARIAN CANCER. THE FOLLOWING RESULTS WERE PROVIDED: (LAB REFERENCE RANGE FOR CA125 <35 KU/L) (B)(6) 2026, SID (B)(6) INITIAL RESULT = 10 KU/L, (B)(6) 2026 REPEAT RESULT = 899 KU/L, RESULT AFTER 1:10 DILUTION = 1008 KU/L . NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24647581 ↗InjuryApr 24, 2024High Test Results; High Test Results
UPDATE: ADDITIONAL CLARIFYING INFORMATION WAS RECEIVED FROM THE CUSTOMER: THE ADDITIONAL TESTING AND SCANS WERE COMPLETED AFTER THE INITIAL RESULTS FROM (B)(6) 2024 WERE REPORTED. (B)(6) 2024: CERVICAL SMEAR FOR CYTOLOGY. (B)(6) 2024: G&C SCOPE. (B)(6) 2024: ENDOMETRIAL BIOPSY. THE DATES OF THE OTHER TESTING/SCANS ARE UNKNOWN. THE DETAILS OF THE FAMILY HISTORY OF CANCER IS UNKNOWN. NO FURTHER IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19176985 ↗
Other TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125) devices
- ADVIA Centaur® CA 125II 10310443Siemens Healthcare Diagnostics Inc. · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)1 recall10 reports
- ADVIA Centaur® CA 125 II 10315696Siemens Healthcare Diagnostics Inc. · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)1 recall0 reports
- ARCHITECT 02K4529Abbott GmbH · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)8 reports
- Atellica IM CA 125II 10995482Siemens Healthcare Diagnostics Inc. · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)3 reports
- ARCHITECT 02K4539Abbott GmbH · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)3 reports
- Elecsys CA 125 II Assay 11776223161Roche Diagnostics GmbH · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)2 reports
- Alinity 08P4920Abbott GmbH · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)2 reports
- IMMULITE® 2000 Systems OV OM-MA (CA125) 10380972Siemens Healthcare Diagnostics Products Ltd · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)2 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.